8:40am ET
Health and Healthcare
UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
Companies
Celgene
$108.24
▲ $0.00 (+0.00%) today
Markets closed · 5:14pm ET
CELG Coverage
Page 21
2:05pm ET
Health and Healthcare
Will Celgene Trigger Other Biotech Stock Splits?
Celgene has decided to join the stock split game. Even though stock splits change nothing fundamentally, 24/7 Wall St. would like to see several competing biotechs join in on the fun.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Amazon, Celgene, Cisco, FedEx, Starbucks and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 19, 2014. They include Amazon.com, Celgene, Cisco Systems, FedEx and Starbucks.
6:50am ET
Health and Healthcare
Short Sellers Remain Vigilant Against Top Biotech Stocks
ThinkstockShort sellers have many reasons to bet against a stock, some of which are hedging or part of a larger theme. Other reasons may be a bet against a company or sector,…
9:25am ET
Health and Healthcare
Large Cap Biotech Stocks to Buy Leading the Comeback Rally
A new research note from Credit Suisse maintains that the top large cap biotech leaders are leading the comeback rally from the hard sell-off. Here are the top large cap biotech stocks…
7:55am ET
Investing
Top Analyst Upgrades and Downgrades: AngloGold, Twitter, Biogen, Celgene, HomeAway, VMware and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, May 29, 2014. They include AngloGold Ashanti, Twitter, Biogen Idec, Celgene, HomeAway and VMware.
8:40am ET
Health and Healthcare
Three Companies That Want to Cure Pancreatic Cancer
A new research report from Cowen cautions that progress on a cure for pancreatic cancer is slow, but steady. Drugs from three companies though have been favorably viewed by consultants.
8:35am ET
Investing
RBC Doctor Panel Picks in Drugs and Biotech
In a new research report, the pharmaceutical and biotech analysts at RBC highlight their meetings with a group of six physicians. They favor four top stocks now as best positioned for continued…
10:50am ET
Health and Healthcare
Companies Betting on the Next 10 Blockbuster Drugs
24/7 Wall St. wanted to evaluate the prospects for several would-be blockbuster drugs. Some of these have approvals already in hand, while others have pending FDA approval verdicts.
8:50am ET
Health and Healthcare
UBS Top Stocks to Buy Working for Cancer Cures
In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are making major advances in cancer therapeutics. Here is the UBS list of…
12:00pm ET
Health and Healthcare
Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene
ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off of momentum stocks in a reality check. The problem is that after…
8:00am ET
Health and Healthcare
Who Bucked the Short Interest Trend in Biotech Stocks?
Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many of them.…
8:25am ET
Health and Healthcare
Credit Suisse Says Grit Your Teeth and Buy Biotech
In a new report, the Credit Suisse team says large cap biotech is cheaper than the S&P 500 on 2016 and 2017 numbers. Here are the top biotech names rated Outperform at…
8:20am ET
Health and Healthcare
Stifel Says Strong Earnings Will Reignite Biotech Rally
ThinkstockWhen the biotech sell-off started in late February, the stocks had been market leaders for almost four years. The staggering and intense selling knocked a quick 17% off the index and immediately…
3:37pm ET
Health and Healthcare
Biotech Giants Now Priced Like Old World Drug Stocks
Most investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position against stock market volatility. Investors who are buying biotechs generally are looking for…